TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
出版年份 2021 全文链接
标题
TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume -, Issue -, Pages 1-18
出版商
Informa UK Limited
发表日期
2021-04-17
DOI
10.1080/14728222.2021.1918103
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The neuroinvasive potential of SARS‐CoV2 may be at least partially responsible for the respiratory failure of COVID‐19 patients
- (2020) Yan‐Chao Li et al. JOURNAL OF MEDICAL VIROLOGY
- Toll-like receptor 4 agonist and antagonist lipopolysaccharides modify innate immune response in rat brain circumventricular organs
- (2020) Alejandra Vargas-Caraveo et al. Journal of Neuroinflammation
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- (2020) Nanshan Chen et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
- (2020) Qun Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for the recognition of the SARS-CoV-2 by full-length human ACE2
- (2020) Renhong Yan et al. SCIENCE
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanisms
- (2020) Abdul Mannan Baig et al. ACS Chemical Neuroscience
- Nervous system involvement after infection with COVID-19 and other coronaviruses
- (2020) Yeshun Wu et al. BRAIN BEHAVIOR AND IMMUNITY
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study
- (2020) Andrea Giacomelli et al. CLINICAL INFECTIOUS DISEASES
- Pathogenesis of COVID-19 from a cell biology perspective
- (2020) Robert J. Mason EUROPEAN RESPIRATORY JOURNAL
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
- (2020) Takeshi Moriguchi et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Neurological manifestations and complications of COVID-19: A literature review
- (2020) Imran Ahmad et al. JOURNAL OF CLINICAL NEUROSCIENCE
- In silico studies on the comparative characterization of the interactions of SARS‐CoV‐2 spike glycoprotein with ACE‐2 receptor homologs and human TLRs
- (2020) Abhigyan Choudhury et al. JOURNAL OF MEDICAL VIROLOGY
- Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19)
- (2020) Dae-Gyun Ahn et al. JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neurologic Features in Severe SARS-CoV-2 Infection
- (2020) Julie Helms et al. NEW ENGLAND JOURNAL OF MEDICINE
- Taste and smell disorders in COVID-19 patients: role of Interleukin-6
- (2020) Angela Pia Cazzolla et al. ACS Chemical Neuroscience
- The cytokine storm of COVID-19: a spotlight on prevention and protection
- (2020) Lucie Pearce et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports
- (2020) Souhel Najjar et al. Journal of Neuroinflammation
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview
- (2020) Alessio Romerio et al. Frontiers in Immunology
- Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study
- (2020) Yanan Li et al. JOURNAL OF INVESTIGATIVE MEDICINE
- Nrf2 Activator PB125® as a Potential Therapeutic Agent against COVID-19
- (2020) Joe M. McCord et al. Antioxidants
- Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission
- (2020) Daniella S. Battagello et al. CLINICAL SCIENCE
- Neurological manifestations of COVID-19: available evidences and a new paradigm
- (2020) Fatima Khatoon et al. JOURNAL OF NEUROVIROLOGY
- Author Correction: Targeting QKI-7 in vivo restores endothelial cell function in diabetes
- (2020) Chunbo Yang et al. Nature Communications
- Linear and Rationally Designed Stapled Peptides Abrogate TLR4 Pathway and Relieve Inflammatory Symptoms in Rheumatoid Arthritis Rat Model
- (2019) Asma Achek et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ferulic acid inhibits bovine endometrial epithelial cells against LPS-induced inflammation via suppressing NK-κB and MAPK pathway
- (2019) Peng Yin et al. RESEARCH IN VETERINARY SCIENCE
- Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
- (2019) Marc Desforges et al. Viruses-Basel
- Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists
- (2018) Fabio A. Facchini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses
- (2018) Tong-gang Liu et al. MICROBIAL PATHOGENESIS
- Toll-like receptor 4 in acute viral infection: Too much of a good thing
- (2018) Judith Olejnik et al. PLoS Pathogens
- Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)- and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling
- (2017) Stefania E. Sestito et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
- (2016) X Wang et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibitory effects of parthenolide on the activity of NF-κB in multiple myeloma via targeting TRAF6
- (2015) Fan-cong Kong et al. Journal of Huazhong University of Science and Technology-Medical Sciences
- Effects of Eleutheroside B and Eleutheroside E on activity of cytochrome P450 in rat liver microsomes
- (2014) Sixun Guo et al. BMC Complementary and Alternative Medicine
- Chemistry of Lipid A: At the Heart of Innate Immunity
- (2014) Antonio Molinaro et al. CHEMISTRY-A EUROPEAN JOURNAL
- Toll-Like Receptor Signaling Pathways
- (2014) Takumi Kawasaki et al. Frontiers in Immunology
- Virus Infections in the Nervous System
- (2013) Orkide O. Koyuncu et al. Cell Host & Microbe
- Alpinetin inhibits LPS-induced inflammatory mediator response by activating PPAR-γ in THP-1-derived macrophages
- (2013) Ke Hu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A recombinant anchorless respiratory syncytial virus (RSV) fusion (F) protein/monophosphoryl lipid A (MPL) vaccine protects against RSV-induced replication and lung pathology
- (2013) Jorge C.G. Blanco et al. VACCINE
- Parthenolide inhibits TRIF-dependent signaling pathway of toll-like receptors in RAW264.7 macrophages
- (2011) Se-Jeong Park et al. MOLECULES AND CELLS
- Endogenous toll-like receptor ligands and their biological significance
- (2010) Li Yu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules
- (2010) N. Matsunaga et al. MOLECULAR PHARMACOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Analysis of binding site for the novel small-molecule TLR4 signal transduction inhibitor TAK-242 and its therapeutic effect on mouse sepsis model
- (2009) K Takashima et al. BRITISH JOURNAL OF PHARMACOLOGY
- Berberine Modifies Cysteine 179 of I B Kinase, Suppresses Nuclear Factor- B-Regulated Antiapoptotic Gene Products, and Potentiates Apoptosis
- (2008) M. K. Pandey et al. CANCER RESEARCH
- Identification of Oxidative Stress and Toll-like Receptor 4 Signaling as a Key Pathway of Acute Lung Injury
- (2008) Yumiko Imai et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now